Ubs Group Ag Better Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.64 - $1.45 $2,399 - $5,436
3,749 Added 1828.78%
3,954 $2,000
Q4 2022

Feb 08, 2023
BUY
$1.1 - $1.74 $225 - $356
205 New
205 $0
Q1 2022

May 16, 2022
SELL
$1.98 - $5.01 $5,878 - $14,874
-2,969 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.58 - $17.14 $13,598 - $50,888
2,969 New
2,969 $14,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0
View Full List

About Better Therapeutics, Inc.

BTTX Quotes by TradingView
  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email